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Abstract
Background—Evaluation of the prevalence and incidence of asthma and research into its 
etiology often rely on self-reported information. We conducted this analysis to investigate 
reliability in reporting asthma history across categories of demographic and socio-economic 
characteristics.
Methods—We analyzed data from 3109 participants in the Coronary Artery Risk Development 
in Young Adults study, a longitudinal study of African-American and white adults. Responses to 
self-administered questionnaires completed at 15- and 20-year follow-up exams were used to 
evaluate agreement in reporting asthma history and age at diagnosis and assess variation in 
agreement across categories of demographic and health-related characteristics.
Results—A history of asthma was reported by 12% of participants at the 15-year exam and 11% 
of participants at the 20-year exam, with 97% agreement and an overall Kappa coefficient of 0.845 
(95% confidence interval: 0.815–0.874). Kappa coefficients were higher among women than men 
and increased monotonically across categories of educational attainment. One-hundred eight 
participants (35%) reported exactly the same age at diagnosis at the two time points; for another 
120 (39%), the difference in reported ages was ≤2 years. Age at asthma diagnosis reported at the 
20-year exam was, on an average, 1 year (SD: 5.2) older than that reported at the 15-year exam.
Conclusions—Five-year reliability in self-reported asthma history is high, and variation in 
reporting age at diagnosis is low across categories of participant characteristics. Nevertheless, 
agreement in responses at two times does not guarantee that self-administered questionnaires are 
sensitive tools for detecting a true asthma history.
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Introduction
Evaluation of the prevalence and incidence of asthma and research into its etiology often 
rely on self-reported asthma histories provided by adult research subjects and survey 
respondents. However, relatively little information is available about the extent to which 
responses to specific questionnaire items designed to identify men and women with a history 
of physician-diagnosed asthma truly provide the information about the history of asthma or 
the timing of its onset that investigators seek. Indeed, one of the major disadvantages of 
developing and using a questionnaire to identify asthma is the lack of a widely-accepted 
definition of asthma with which to compare questionnaire responses [1].
Guidelines by the National Heart Lung and Blood Institute provide a working definition of 
asthma by identifying asthma as a common chronic inflammatory disorder of the airways 
characterized by variable and recurring symptoms, airway obstruction and bronchial 
hyperresponsiveness [2]. Developed for clinical use, these guidelines provide parameters for 
asthma diagnosis and the development of asthma treatment plans. The accuracy with which 
patients are diagnosed and later recall and report diagnoses made according to such 
parameters unmistakably affects the use of self-reported asthma history information in 
epidemiologic research. One evaluation of the validity of questionnaire-based responses to 
provide the same information generated by non-specific tests of bronchial 
hyperresponsiveness or clinical diagnoses suggests that self-reported questionnaire 
responses are generally characterized by low sensitivity and high specificity [1]. That is, the 
proportion of individuals with asthma identified using survey responses as having asthma is 
low, while the proportion of individuals without asthma who are identified as not having 
asthma is high [1,3].
The integration of information reported over time through the repeated use of an asthma 
questionnaire has been proposed as a means to improve the characterization of asthma, 
particularly among individuals for whom the manifestation of asthma changes over time [4]. 
In a recent comparison of asthma classification based on physiologic measures during a 
clinical exam to self-reported asthma reported 10 years after the clinical exam, Torén et al. 
describe an observed bias in self-reported asthma attributable to asthma severity [5,6]. 
Specifically, adults with mild asthma at the beginning of the follow-up period were less 
likely to self-report their asthma 10 years later. In the absence of a clinical examination, 
such as that available to Torén et al. and Balder et al. [5,6], adult participants in 
observational research studies may be asked whether they have ever had asthma, ever been 
diagnosed with asthma or ever been told by a doctor or nurse that they have asthma.
Given the likelihood of low sensitivity and high specificity of questionnaire items related to 
asthma, evaluation of the reliability of reporting asthma is uncommon and the extent to 
which study participants provide the same information about their history of asthma when 
they are asked on more than one occasion is largely unknown, particularly among 
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participants recruited into general population-based research studies. In an evaluation of 
initial responses to those provided approximately eight years later by participants in the 
European Community Respiratory Health Survey, Pattaro et al. reported 96% agreement in 
responses about a lifetime history of asthma and a mean difference of −0.20 years in the 
reported age at first asthma attack [7]. The extent to which these results may be generalized 
across demographic and socio-economic categories is unknown. As in the European 
Community Respiratory Health Survey, participants in the Coronary Artery Risk 
Development in Young Adults (CARDIA) study responded to questions about their 
respiratory health multiple times. In the CARDIA study, identical questionnaire items 
included at follow-up examinations that occurred five years apart provide a unique 
opportunity to investigate reliability in reporting a history of asthma and, among adults with 
a history of asthma, the age at which the asthma diagnosis occurred. We conducted these 
analyses to extend our understanding of the validity and reliability of self-reported asthma 
history information by investigating reliability in reporting asthma history and age at asthma 
onset across categories of demographic, socio-economic and health-related characteristics.
Methods
The CARDIA study
We analyzed publicly available data from the CARDIA study, a prospective, population-
based cohort study designed to assess the development of heart disease in African-American 
and white adults [8,9]. The CARDIA study enrolled a closed cohort of men and women, 
aged 18–30 years, from four communities in the United States: Birmingham, AL; 
Minneapolis, MN; Chicago, IL; and Oakland, CA. Initial examination of the study 
population occurred in 1985–1986 with a baseline exam completed by 5112 participants. At 
the baseline exam, each participant provided detailed demographic and health-related 
information. Follow-up examinations occurred 2, 5, 7, 15, 20 and 25 years after the baseline 
exam. The study design and methods are described in detail elsewhere [8–10]. Selected 
CARDIA data through the 20-year follow-up exam are publicly available through the 
Biologic Specimen and Data Repository Information Coordinating Center of the National 
Heart Lung and Blood Institute [11]. Because we used only these de-identified, publicly-
available data, the analyses presented in this study were reviewed and determined to be 
exempt from Institutional Review Board review at the Centers for Disease Control and 
Prevention.
Study population
Medical history questionnaires administered at the 15- and 20-year follow-up examinations 
(hereafter referred to as Y15 and Y20, respectively) contained identical questions about 
asthma history, and therefore formed the basis for selecting the study population to be 
included in our analysis. To evaluate the reliability in reporting asthma history and age at 
asthma onset, we limited our eligible study population to the 3177 CARDIA participants 
who completed medical history questionnaires at both Y15 and Y20. We excluded one 
participant with incompatible information about age at the Y20 exam and age at asthma 
diagnosis and 67 participants with new-onset asthma during the follow-up period – that is, 
individuals who reported no history of asthma before or at Y15 and who subsequently 
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reported a history of asthma consistent with the first onset of asthma between Y15 and Y20. 
Among the 67 excluded, due to new-onset asthma, 27 reported an age at diagnosis consistent 
with onset between the Y15 and Y20 exams, 38 reported an age at diagnosis younger (range: 
1–20 years younger; median: 4.5) than his/her age at the Y15 exam and 2 did not report an 
age at diagnosis. After these exclusions, our analyses are based on a final study population 
of 3109 participants.
Asthma history
At the baseline, Y15 and Y20 exams, participants self-reported a history of asthma by 
responding to the following question: “has a doctor or nurse ever said that you have 
asthma?” Respondents who indicated that they were “not sure” (at Y15 only: n =14; at Y20 
only: n =34; at both: n =2) were categorized as not having been told by a doctor or nurse that 
they have asthma. Those participants with a history of asthma then reported his/her age at 
asthma diagnosis by responding to the follow-up question “at what age were you first told 
this?”.
Other covariates
Each participant reported his/her age, race and sex. We used responses provided at Y20 to 
categorize participants’ educational attainment, family income, usual source of medical care, 
cigarette smoking status and body mass index. For participants without valid information 
about educational attainment or usual source of medical care at Y20, we carried forward 
responses provided at Y15. Cigarette smoking status was categorized as current smoker, 
former smoker or lifetime non-smoker. All 24 participants for whom a current smoking 
status was not reported at Y20 had reported either currently or formerly smoking in earlier 
exams, therefore, we carried forward to Y20 the last reported current or former smoking 
status. Body mass index values were categorized: 18.5–24.9 (normal), 25.0–29.9 
(overweight) and ≥30.0 (obese). None of the participants’ body mass index values were 
below the threshold for underweight (<18.5); 14 individuals for whom body mass index 
values were missing at Y20 were also missing the information at Y15 and are categorized 
here as having unknown body mass index.
At Y20, 3020 (97%) participants completed spirometry testing. We used participants’ 
maximum forced expiratory volume in one second (FEV1), maximum forced vital capacity 
(FVC) and reference values for the lower limits of normal (LLN) [12] to categorize 
participants with FEV1<LLN and FEV1/FVC<LLN as having airway obstruction at Y20.
Statistical analysis
We evaluated agreement in reporting a history of asthma at Y15 and Y20 by percent 
agreement and Cohen’s kappa coefficients [13], which are presented with 95% confidence 
intervals (CIs) generated using asymptotic standard errors. To investigate variations in 
agreement across categories of demographic, socio-economic and health-related 
characteristics, we computed metrics of agreement for each stratum of age, race, sex, 
educational attainment, family income, usual source of medical care, smoking status, airway 
obstruction and body mass index. Differences in stratum-specific kappa coefficients were 
examined using the test for equal kappa coefficients.
Mirabelli et al. Page 4
J Asthma. Author manuscript; available in PMC 2015 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Following this main analysis of agreement in reporting a history of asthma, we conducted 
two sensitivity analyses designed to evaluate the impact on our results of two analytic 
decisions: (1) categorizing as not having a history of asthma 50 participants who indicated 
that they were not sure whether they had ever been told they had asthma or whose responses 
to the question were missing and (2) categorizing 38 participants as having new-onset 
asthma during follow-up despite an age at asthma diagnosis reported as younger than the age 
at Y15. Our main analysis treated these 38 respondents as if they correctly reported no 
history of asthma at Y15 and a new history of asthma at Y20, but incorrectly recalled and 
reported the age at diagnosis as having occurred before the Y15 exam. In contrast, we 
designed this sensitivity analysis to evaluate the impact of treating these participants as if 
they incorrectly reported no history of asthma at Y15 then correctly reported a history of 
asthma and age at asthma diagnosis at Y20. In the sensitivity analysis, we treated larger 
differences between age at asthma diagnosis and age at Y15 more likely to be false negative 
responses at Y15 and smaller differences more likely to be true negative responses at Y15 
followed by new-onset asthma between Y15 and Y20 and poor recall of age at which the 
diagnosis occurred. In the absence of a threshold for which differences may be considered 
false negative asthma histories versus true negatives with poorly recalled age at diagnosis, 
we evaluated the change in kappa as participants were sequentially added to the study 
population in descending order of the number of years between the age at Y15 and the age at 
asthma diagnosis reported at Y20.
Among adults who reported a history of asthma at both Y15 and Y20, we evaluated 
agreement in reported age at asthma diagnosis using Pearson’s product-moment correlation 
coefficients. The magnitude of discordance in the values of age at asthma diagnosis reported 
at Y15 and Y20 was computed as the difference in the ages reported at the two time points. 
We evaluated variations in these differences across strata of age, race, sex, educational 
attainment, family income, usual source of medical care, smoking status, airway obstruction 
and body mass index.
Finally, to examine changes in the estimated sensitivity and specificity of self-reporting a 
history of asthma by age 17 over time, we selected a subpopulation of 2788 CARDIA 
participants who returned for follow-up exams at years 7, 10, 15 and 20. Responses at the 
baseline exam and each follow-up exam were used to categorize participants as reporting a 
history of asthma with onset by age 17. The sensitivity of self-reporting a history of asthma 
diagnosed at 0–17 years of age was calculated at each of the four follow-up exams by 
dividing the number of participants whose responses indicated a history of asthma at ≤17 
years of age by the number of participants with positive responses at the baseline exam (n 
=216). Similarly, specificity was calculated by dividing the number of participants whose 
responses indicated no history of asthma by age 17 by the number of participants with 
negative responses at the baseline exam (n =2572). At each follow-up exam, positive 
predictive values were calculated by dividing the number of participants with positive 
responses at both the baseline and the follow-up exam by the number of participants with 
positive responses at the follow-up exam; negative predictive values were calculated by 
dividing the number of participants with negative responses at both the baseline and the 
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follow-up exam by the number of participants with negative responses at the follow-up 
exam. All analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC).
Results
A history of asthma was reported by 12% of respondents at the 15-year exam and 11% of 
respondents at the 20-year exam, with 97% agreement in responses at the two exams and an 
overall Kappa coefficient of 0.845 (95% CI: 0.815–0.874) (Table 1). Kappa coefficients 
were higher among women (0.870; 95% CI: 0.836–0.904) than men (0.797; 95% CI: 0.741–
0.853), lower among respondents aged 38–40 years at the time of the 20-year follow-up 
exam (0.751; 95% CI: 0.637–0.864) than adults aged 41–50 years (0.856; 95% CI: 0.825–
0.886) and increased monotonically across categories of educational attainment. There was 
little variation in the magnitude or precision of Kappa coefficients generated across 
categories of race, family income, usual source of medical care, smoking status or airway 
obstruction (Table 2).
By re-evaluating agreement when 50 participants who responded that they were not sure 
whether they had ever been told they had asthma or whose responses to the question were 
missing were included in a third category (“not sure”), rather than categorized as not having 
a history of asthma, agreement in responses at the two exams was reduced to 96%, with a 
weighted Cohen’s kappa of 0.458 (95% CI: 0.369–0.547) among men, 0.676 (95% CI: 
0.597–0.754) among women and 0.587 (95% CI: 0.525–0.648) overall. Of the 16 men and 
women categorized as “not sure” at Y15, 11 (69%) reported no history of asthma at Y20. 
Although spirometry data are not available for Y15, 13 of 14 who completed spirometry at 
Y20 were categorized as not having airway obstruction at Y20. Of the 36 participants 
categorized as “not sure” at Y20, 25 (69%) reported no history of asthma at Y15 and 30 of 
33 who completed spirometry at Y20 were categorized as not having airway obstruction. 
Excluding these, 50 participants generated agreement in responses at the two exams of 97% 
and a kappa of 0.861 (95% CI: 0.833–0.889) for the remaining population.
Results of analyses designed to consider the impact of excluding participants based on our 
categorization of new-onset asthma during the five-year follow-up period (i.e. participants 
who reported no history of asthma at Y15, then reported at Y20 an age at asthma diagnosis 
that was younger than the age at which the Y15 exam took place) are presented in Figure 1. 
For these 38 participants, the reported age at asthma diagnosis was an average of 6.3 (SD: 
4.9; median: 4.5) years younger than the age at which the Y15 exam was completed. The 
range of ages at asthma diagnosis reported (range: 25–40 years) may suggest a history of 
adult-onset asthma that was unreported at Y15. As participants with a greater age 
differences were sequentially included in the analysis, kappa coefficients declined to 0.759 
(95% CI: 0.699–0.818) among men, 0.814 (95% CI: 0.775–0.853) among women and 0.796 
(95% CI: 0.763–0.828) overall.
Of the 318 participants who reported a history of asthma at both Y15 and Y20, 308 (97%) 
also reported an age at asthma diagnosis and were included in our analysis of agreement in 
the reporting of age at asthma diagnosis. The mean age at asthma diagnosis reported was 
18.2 (SD: 12.3) years at Y15 and 19.2 (SD: 12.2) years at Y20 (Table 3). One-hundred eight 
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participants (35%) reported exactly the same age at asthma diagnosis at both exams; for 
other 120 (39%) participants, the difference in reported ages was ≤2 years.
Among the 216 participants who, at the baseline exam, reported a history of asthma 
diagnosed at ≤17 years of age, 151 again reported a history of asthma diagnosed at ≤17 
years at the Y7 exam for a sensitivity of 0.70; sensitivity decreased monotonically across 
subsequent exams: 0.67 at Y10, 0.65 at Y15 and 0.59 at Y20 (Table 4). Among the 2572 
participants without a history of asthma at ≤17 years of age, specificity exceeded 0.98 across 
the four follow-up exams. Across the four follow-up periods, there was little variation in 
positive and negative predictive values; positive predictive values ranged from 0.79 to 0.81 
and negative predictive values ranged from 0.97 to 0.98.
Discussion
Our study, designed to characterize the reliability of self-reported asthma history, suggests 
that five-year reliability in self-reported history of asthma is high across categories of age, 
race, sex, educational attainment, family income, source of medical care, smoking status, 
airway obstruction and body mass index. Agreement in reporting a history of asthma was 
slightly higher among women than among men and increased across categories of 
educational attainment. Among adults who reported a history of asthma at both time points, 
the difference in the ages at which asthma was reportedly diagnosed was less than or equal 
to two years for nearly 75% of respondents. Overall, these findings indicate that data 
collected via self-administered questionnaire are a reliable source of information about 
lifetime asthma history and age at asthma diagnosis. Our evaluation of the sensitivity of self-
reported asthma among adults who, at the baseline exam, reported a history of asthma that 
was diagnosed at 0–17 years of age and our finding of decreasing sensitivity between the 7-
to 20-year follow-up exams further suggest that while five-year reliability may be high, 
recall of a history of childhood asthma changes over time.
Without a “gold standard” with which to compare survey responses, agreement in reporting 
asthma history at two exams does not guarantee that the self-administered questionnaire 
items are a sensitive tool for detecting a true history of asthma or the timing of its onset. 
Indeed, without information about an individual’s true asthma status, analysis of sensitivity 
and specificity of self-report asthma history is limited to the comparison of proxy metrics of 
true asthma status. As a proxy measure of true asthma status at ages 0–17 years, we used the 
earliest available responses, which were given at 18–30 years of age. The sensitivity and 
specificity of subsequent, identical survey questions to provide the same information as the 
earliest responses shows the extent to which information about asthma history collected 
using standard questionnaire items changes over time. The declining sensitivity and 
consistently high specificity and negative predictive values we observed are all consistent 
with the range of values reported for the validity of self-reported asthma history as a means 
to identify individuals with positive non-specific bronchial challenge tests [1]. Comparisons 
of self-reported asthma with other proxy measures of true asthma status suggest that the 
correlations between self-reported responses and existing records vary by the source of the 
existing records [14,15]. Comparisons of self-reported, physician-diagnosed asthma to 
objective metrics of symptoms, airway obstruction or bronchial hyperresponsiveness would 
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improve our understanding of which features of asthma most influence self-reporting. Our 
analyses revealed small differences in reliability in self-reported asthma history or age at 
asthma diagnosis between individuals with or without airway obstruction; nonetheless, 
complete information about study participants’ true asthma status, including variable and 
recurring symptoms, airway obstruction, bronchial hyperresponsiveness and other indicators 
of asthma status and severity, would also improve our understanding of the extent to which 
the previously reported bias by asthma severity [5,6] may differentially affect the reliability 
of self-reported asthma history.
We measured agreement in reporting a history of asthma using Cohen’s kappa coefficient, a 
metric for evaluating inter-rater reliability while correcting for the probability of agreement 
by chance [16]. The influence of the prevalence of the outcome on the magnitude of kappa 
[17] suggests that while the five-year reliability observed in our study is high, the specific 
kappa coefficients generated using these data may not be applied to studies in which the 
prevalence of asthma differs considerably from the 11–12% prevalence observed in this 
general population-based cohort. Thus, while our results provide information about the 
reliability of reported asthma history and age at asthma diagnosis in a general population-
based sample of African-American and white adults, they may not accurately reflect the 
reliability of information provided by participants of other racial, ethnic or high-risk groups. 
Our results also do not provide information about the reliability of responses reported in 
languages other than English or the reliability of information collected using variations in 
terminology to describe asthma; nor do our findings aid the interpretation of information 
collected among patients in clinical settings or about other self-reported health conditions. 
Evaluation of reliability of information provided by a wide range of study participants would 
further improve our understanding of the reliability of asthma history information collected 
for epidemiologic research.
Ideally, responses to “have you ever had asthma?”, “has a doctor or nurse ever told you that 
you have asthma?” and “was it confirmed by a doctor?” should all provide the same 
information. Inconsistent responses may indicate gaps in discussions between patients and 
healthcare providers. If patients opt not to discuss symptoms with their healthcare providers, 
if patient-provider discussions do not confirm or refute patients’ beliefs about whether they 
have asthma, or if patients who suspect they have asthma do not seek medical attention for 
their symptoms, then those patients’ responses about whether they have asthma may differ 
appropriately from their responses about whether a doctor or nurse has ever confirmed the 
asthma. Improvements in discussions between patients and healthcare providers may very 
well improve the quality of asthma history information provided in research settings. In 
prospective research studies, the integration of measurements of bronchial reactivity and 
self-reported information about respiratory symptoms, asthma diagnosis and age at asthma 
onset would improve the ability of investigators to interpret information provided at later 
time points about existing or new respiratory symptoms or conditions.
Interpretation of our results is aided by several notable study strengths: the large numbers of 
African-American and white men and women in the CARDIA study population, use of 
identically worded questionnaire items about asthma history and the low attrition indicated 
by percentages of the surviving cohort re-examined at each follow-up exam (i.e. 81% at Y7; 
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79% at Y10; 74% at Y15; and 72% at Y20) [18]. In particular, the sufficiently large study 
population allowed us to conduct two informative sensitivity analyses. First, our analysis of 
the impact of categorizing respondents who reported that they were “not sure” whether they 
had been told by a doctor or nurse that they had asthma indicates that these respondents may 
be categorized as not having asthma, rather than excluded from analysis, with little impact 
on reliability. Collecting additional information about respiratory symptoms, bronchial 
hyperresponsiveness and other health indicators among people who respond that they are 
“not sure” would facilitate the correct categorization of these responses. In our analyses, we 
evaluated the presence of airway obstruction among participants with uninformative 
responses about asthma status and identified few participants with airway obstruction; 
although airway obstruction is not an indicator of asthma status, the low prevalence of 
airway obstruction in this population does not suggest that impaired lung function may 
explain these uninformative responses. In the absence of additional information about the 
symptoms or health of individuals who responded that they were “not sure”, 
misclassification may be low if these individuals are categorized as not having a history of 
asthma. Our second sensitivity analysis considered the possibility that we incorrectly 
identified 38 participants as having new-onset asthma and excluded them from our analysis. 
Following our analysis, it seems reasonable to conclude that some participants may have 
incorrectly reported an age at diagnosis as being earlier than it actually occurred; these 
participants would have been correctly excluded from our main analysis. However, if some 
participants, particularly those who at Y20 reported an age at diagnosis more than 10 or 20 
years ago, incorrectly reported no history of asthma at Y15, then we excluded needlessly 
from our main analysis participants with discrepant responses, and the reliability we report 
may be higher than the true reliability in this population. Without an a priori hypothesis 
regarding the number of years before the last data collection time point that we would 
consider the response to be an incorrectly reported age at asthma diagnosis, we opted to 
include Figure 1 so that readers may consider for themselves the effects of misclassification 
of asthma history at Y15 and age at diagnosis reported at Y20 on estimates of reliability 
among men and women.
Conclusions
These results extend our understanding of the validity of self-reported asthma [5,6] by 
showing that among African-American and white adult study participants in the United 
States, reliability is high across categories of demographic and socio-economic 
characteristics. The modest, but clear, differences observed in reliability by sex and across 
categories of education attainment suggest that misclassification of asthma status may be 
influenced by demographic and socio-economic factors and that when asthma history is of 
interest, attention to the potential for such misclassification may improve the use of asthma 
history information provided by study participants. Evaluation of self-reported asthma 
among adults who, at the baseline exam, reported a history of asthma that was diagnosed at 
0–17 years of age and our findings of stable specificity, positive predictive value and 
negative predictive value over time accompanied by decreasing sensitivity suggest that 
while five-year reliability may be high, recall of a history of childhood asthma may change 
over time.
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Figure 1. 
Changes in Kappa coefficients as participants categorized as having new-onset asthma were 
added to the final study population (marked “F”; n =3109) in the order of decreasing years 
that reported age at asthma diagnosis preceded participant age at the 15-year follow-up. 
Diamond symbols show where one or more participants were added to the study population.
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Table 1
Responses to the question “has a doctor or nurse ever said that you have asthma?” and Kappa coefficient of 
agreement in responses provided at the 15- and 20-year follow-up exams.
Asthma reported at 15-year follow-up exam
Asthma reported at 20-year follow-up exam
Kappa (95% CI)
No Yes
N (%) N (%)
No 2690 (86.5) 32 (1.0) 0.845 (0.815–0.874)
Yes 69 (2.2) 318 (10.3)
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Table 2
Characteristics of the CARDIA study population at the 20-year follow-up exam and agreement in reporting a 
history of asthma at 15- and 20-year follow-up exams.
Characteristics of study participants at the 20-year follow-up 
exam N (%) Kappa (95% CI) Test for equal kappa coefficientsa
Total 3109 (100.0) 0.845 (0.815–0.874)
Age, in years χ2 =9.93, 5 df, p =0.077
 38–40 404 (13.0) 0.751 (0.637–0.864)
 41–42 372 (12.0) 0.876 (0.807–0.945)
 43–44 448 (14.4) 0.821 (0.743–0.899)
 45–46 527 (17.0) 0.844 (0.771–0.916)
 47–48 627 (20.2) 0.916 (0.862–0.971)
 49–50 731 (23.5) 0.832 (0.770–0.893)
Race χ2 =0.308, 1 df, p =0.579
 Black 1384 (44.5) 0.836 (0.793–0.879)
 White 1725 (55.5) 0.853 (0.812–0.893)
Sex χ2 =4.786, 1 df, p =0.029
 Female 1747 (56.2) 0.870 (0.836–0.904)
 Male 1362 (43.8) 0.797 (0.741–0.853)
Educational attainment, in years χ2 =5.946, 3 df, p =0.114
 ≤12 724 (23.3) 0.800 (0.733–0.868)
 13–15 839 (27.0) 0.841 (0.787–0.895)
 16 816 (26.2) 0.842 (0.781–0.902)
 ≥17 730 (23.5) 0.901 (0.849–0.952)
Family income χ2 =6.418, 7 df, p =0.492
 $12 000–$15 999 297 (9.6) 0.829 (0.743–0.916)
 $16 000–$24 999 154 (5.0) 0.791 (0.629–0.952)
 $25 000–$34 999 198 (6.4) 0.919 (0.841–0.997)
 $35 000–$49 999 386 (12.4) 0.786 (0.685–0.887)
 $50 000–$74 999 594 (19.1) 0.847 (0.780–0.914)
 $75 000–$99 999 485 (15.6) 0.815 (0.723–0.906)
 ≥$100 000 952 (30.6) 0.869 (0.819–0.919)
 Not reported 43 (1.4) 0.870 (0.696–1.000)
Usual source of medical care χ2 =1.581, 3 df, p =0.664
 None 282 (9.1) 0.783 (0.646–0.920)
 Private or personal physicianb 2390 (76.9) 0.847 (0.814–0.881)
 Other clinic, by appointment 212 (6.8) 0.823 (0.711–0.935)
 Other 225 (7.2) 0.880 (0.793–0.967)
Cigarette smoking status χ2 =2.645, 2 df, p =0.267
 Lifetime nonsmoker 1911 (61.5) 0.832 (0.792–0.872)
 Former smoker 618 (19.9) 0.836 (0.768–0.904)
 Current smoker 580 (18.7) 0.886 (0.832–0.941)
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Characteristics of study participants at the 20-year follow-up 
exam N (%) Kappa (95% CI) Test for equal kappa coefficientsa
Airway obstruction χ2 =3.140, 2 df, p =0.208
 No 2902 (93.3) 0.834 (0.800–0.867)
 Yes 118 (3.8) 0.858 (0.762–0.953)
 No spirometry data 89 (2.9) 0.927 (0.828–1.000)
Body mass index χ2 =0.227, 2 df, p =0.893
 18.5–24.9 (normal) 895 (28.8) 0.855 (0.798–0.912)
 25.0–29.9 (overweight) 1031 (33.2) 0.837 (0.782–0.892)
 ≥30.0 (obese) 1169 (37.6) 0.839 (0.794–0.885)
 Unknown 14 (0.5) 1.000 (1.000–1.000)
aChi-squared test for equal unweighted Kappa coefficients. Chi-squared test statistics (χ2) are shown with degrees of freedom (df) and p values.
b
Including care available through health maintenance organizations (HMOs).
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